August 2010

ESC: Low-dose heparin+fondaparinux does not lower peri-PCI bleeding, complications ()
ESC: Apixaban trial stopped, cuts AF stroke risk in half ()
Aptus Endosystems secures $15M in financing round ()
ESC: Polyvascular disease, diabetes strongly predict atherothrombosis ()
ESC: Poor metabolizers with ACS should continue on their Plavix ()
Medtronic launches Resolute Integrity DES in EU ()
ESC: Until new anticoagulants arrive, tight INR control needed to prevent stroke ()
ESC: ABCB1 genotype increases CV risk with clopidogrel, but not prasugrel ()
ESC: Brilinta may best Plavix, eliminate need for genetic testing ()
Roundtable: Cost-Control Strategies in the Cath Lab ()
Ochsner Excels with Percutaneous LV Assist Program for High-Risk Patients ()
Solutions for Managing Cath Lab Data & Images ()
Providers & Industry Battle with Conflicts of Interest ()
Sequential or Simultaneous Cardiac PET/CT Which is Best? ()
Transradial Interventions: Helping Cath Labs Stay Cost Savvy ()
The ACC Corner: Managing Rather than Avoiding Industry Relationships ()
Leveraging IT to Boost ECG Efficiency ()
California bill to track rad dose clears one hurdle ()
JACC: Higher cardiac death in DES vs. BMS puzzles researchers ()
Court rejects Sanofi's request for injunctive relief for Lovenox ()
Reducing Heart Failure Readmissions & Rethinking Their Meaning ()
PLoS: Health IT can improve cardiovascular risk management ()
CMS to add VADs as destination therapy to Medicare coverage policy ()
Multi-channel Cardiac MR Seeks to Compete with CCTA ()
First Word: Less Money, More Character? ()
Old Stem Cells Get Boost with New Technique ()
Analog Devices' tech powers Zoll's PocketCPR ()
Circ: Statins acceptable even for intermediate CV risk patients ()
AGA Medical slaps Gore with suit over structural heart device ()
Impax challenges Vytorin patent ()
Circ: Hypertrophic cardiomyopathy linked with long-term survival after transplant ()
JAMA: Intra-aortic pump during PCI shows little difference ()
Circ: Despite ongoing drama, Avandia, Actos have similar CV risks ()
ESC validates troponin as MI biomarker, revises MI definition slightly ()
JACC: FFR trumps IVUS for assessing intermediate lesions for PCI ()
AHA advisory: CV risk in Asian-Americans demands more research ()
Feature: U.S. needs national strategy to curb imaging overutilization ()
FDA weighs safety of Parkinson's therapy after possible CV risk found ()
Report: A-fib market could reach $4.1B by 2015 ()
SCAI, ACCF to help sponsor accreditations of cardiovascular facilities ()
Cedars-Sinai opens doors of advanced heart failure unit ()
Piedmont Heart lands Kandzari and Dean, expands service ()
Intersystems TrakCare gets an upgrade ()
Radiology: Rad role may evolve as image-guided biopsies trend up ()
JACC: Two-device option increases suitability for arotic valve implantation ()
JACC: Same-day discharge safe for uncomplicated PCIs ()
Feature: As Maryland stent investigations continue, more oversight is needed ()
Webinar: Changes in store for Interoperability Showcase, IHE Connectathon ()
EHJ: Cards need to bone up on mitral valve regurgitation guidelines ()
JAMA: Delays in PCI treatment time increase risk of death ()
Wyeth acquisition, international Lipitor sales help Pfizer's Q2 ()
FDA may withdraw low blood pressure drug from U.S. market ()
Contributor: Old cardiac stem cells get boost with new technique ()
Study: Beware the bad attitude, as it may develop into MI, stroke ()
Tailored approach to CPR or rescue breathing could improve outcomes ()
St. Jude recalls 6 French introducers ()
JACC: Plavix adjustment for CYP2C19 gene carriers reduces platelet reactivity ()
GE's Centricity Practice Solution receives CCHIT premarket approval ()
Insurance fraud lands Chicago cardiologist behind bars ()
Study: Generic diuretics = branded hypertension drugs ()
Defibtech, SCAA continue partnership to donate AEDs in critical areas ()
Pennsylvania Amish community gets onboard with AED program ()
Lancet: CRESCENDO halted after diet pill linked to suicides ()
ACC, Duke University unveil study of post-PCI discharge care ()
Adverse drug event? There's an app for that ()
Cardiovascular Systems chips away at net losses ()
Study: Acoustic cardiography trumps stethoscope in diagnosing HF ()
Medicare beneficiaries stuck in donut hole get rebate checks ()
AIM: Attention to multiple CABG quality metrics reduces costs, boosts quality ()
Circulation: Cooling times & methods for cardiac arrest remain uncertain ()
Study: 25% of stroke patients discontinue therapy after discharge ()
FDA, study warn of extended IVC filter usage ()
Merck income drops 51% in Q2, despite strong CV drug sales ()
Hansen narrows net losses in Q2 ()
Federal court says Cordis didn't infringe on Marctec patents ()
AIM: Physicians fall short of heart failure guidelines ()
TARGET-PCI trial to assess value of genetic & platelet function testing ()
Medicines Co. wins one-year patent extension for Angiomax ()
CCI: No radiation protection in the lab could debilitate sight down the road ()
DTB: Pulling diabetes drug from U.K. market could cost $11M+ ()
Circulation: EMS transport to PCI center more cost effective, safer for STEMI ()
JACC: In-lab loading dose of clopidogrel as effective as pre-loading dose ()
SCCT: Downstream CCTA costs compare favorably with SPECT ()
SCCT: Calcium scoring may cut chest pain hospitalizations and costs ()
Abiomed narrows losses in Q1, due to increased Impella sales ()
Review: Patients' refusal of treatment should extend to LVAD removal ()
Medicines Co. sees Q2 income gains on strong Angiomax sales ()
Medicines Co. makes grounds in case against Patent Office ()
Sanofi slaps FDA with lawsuit for approving generic Lovenox ()
Lancet: Autograft root trumps homograft replacement for aortic valve disease ()
CMAJ: PCI for seniors increase over last decade; may help survival ()
Medtronic trials spinal cord stimulation for heart failure ()